Supernus Pharmaceuticals (SUPN) Income towards Parent Company (2011 - 2026)
Supernus Pharmaceuticals' Income towards Parent Company came in at -$58.37 million for Q2 2026, compared with $22.5 million a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Income towards Parent Company (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Supernus Pharmaceuticals reported Income towards Parent Company of -$109.89 million; for FY2025, it was -$38.55 million.
- Going back by year, Income towards Parent Company was $73.87 million in FY2024, $1.32 million in FY2023 (-97.8%), $60.71 million in FY2022 (+13.6%) and $53.42 million in FY2021 (-57.9%).
- The Q2 2026 figure represents the lowest quarterly Income towards Parent Company in data going back to Q1 2011.
- The fastest year-over-year change in Income towards Parent Company over five years came in Q4 2022 (growth of 943.4%), and the weakest in Q1 2024 (a decline of 99.3%).
- Business Quant data shows SUPN's Income towards Parent Company at -$2.29 million (Q1 2026), -$4.11 million (Q4 2025) and -$45.12 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Supernus Pharmaceuticals | 2.47 Bn | 1.12 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58.37 Mn |
| Mar 31, 2026 | -2.29 Mn |
| Dec 31, 2025 | -4.11 Mn |
| Sep 30, 2025 | -45.12 Mn |
| Jun 30, 2025 | 22.50 Mn |
| Mar 31, 2025 | -11.83 Mn |
| Dec 31, 2024 | 15.33 Mn |
| Sep 30, 2024 | 38.50 Mn |
| Jun 30, 2024 | 19.92 Mn |
| Mar 31, 2024 | 124,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | -15.98 Mn |
| Jun 30, 2023 | -831,000.00 |
| Mar 31, 2023 | 16.95 Mn |
| Dec 31, 2022 | 25.48 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 7.87 Mn |
| Mar 31, 2022 | 25.62 Mn |
| Dec 31, 2021 | 2.44 Mn |
| Sep 30, 2021 | 21.56 Mn |
API Access
Supernus Pharmaceuticals Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();